ConductScience.org, home

Paper35767366

Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.

Casadó-Llombart S and 8 others. Prostate, 2022. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution. Papers, record 35767366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35767366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.
PubMed
Journal
Prostate
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.21
iCite
Revised in PubMed
2025-10-31
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Casadó-Llombart SSergihttps://orcid.org/0000-0003-0137-4701
2Ajami TTarekhttps://orcid.org/0000-0002-3505-8232
3Consuegra-Fernández MMartahttps://orcid.org/0000-0002-5894-2768
4Carreras EEstherhttps://orcid.org/0000-0001-9184-8266
5Aranda FFernando
6Armiger NNoelia
7Alcaraz AAntoniohttps://orcid.org/0000-0003-2612-5250
8Mengual LLourdeshttps://orcid.org/0000-0001-7418-9422
9Lozano FFranciscohttps://orcid.org/0000-0003-1119-4368

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Activated-Leukocyte Cell Adhesion MoleculeMajor topic
Prostatic NeoplasmsMajor topic
Antigens, CD
Antigens, Differentiation, T-Lymphocyte
CD5 Antigens
Cell Adhesion
Humans
Lymphocyte Activation
Male
T-Lymphocytes
Tumor Microenvironment

Source PubMed

Download CSV of topics

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126991857Impact of the functional CD5 polymorphism A471V on the response of chronic lymphocytic leukaemia to conventional chemotherapy regimens.Br J Haematol2017https://conductscience.org/library/papers/26991857PubMed
229225340Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis.Cell Mol Immunol2018https://conductscience.org/library/papers/29225340PubMed
327108704Genetic polymorphisms of cell adhesion molecules in Behcet's disease in a Chinese Han population.Sci Rep2016https://conductscience.org/library/papers/27108704PubMed
433125054The T cell CD6 receptor operates a multitask signalosome with opposite functions in T cell activation.J Exp Med2021https://conductscience.org/library/papers/33125054PubMed
515532095Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.J Pathol2005https://conductscience.org/library/papers/15532095PubMed
625402503Analysis of ancestral and functionally relevant CD5 variants in systemic lupus erythematosus patients.PLoS One2014https://conductscience.org/library/papers/25402503PubMed
723128233Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.Nature2012https://conductscience.org/library/papers/23128233PubMed
824385212ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone.Cancer Res2014https://conductscience.org/library/papers/24385212PubMed
931231358Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment.Front Immunol2019https://conductscience.org/library/papers/31231358PubMed
1035767366Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.Prostate2022https://conductscience.org/library/papers/35767366PubMed
1123143596High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.Nat Genet2012https://conductscience.org/library/papers/23143596PubMed
1222006014Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality.Cancer2012https://conductscience.org/library/papers/22006014PubMed
1324740813CD166 regulates human and murine hematopoietic stem cells and the hematopoietic niche.Blood2014https://conductscience.org/library/papers/24740813PubMed
1432630247Immunotherapy in Prostate Cancer.Cancers (Basel)2020https://conductscience.org/library/papers/32630247PubMed
1518519750Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing.Clin Cancer Res2008https://conductscience.org/library/papers/18519750PubMed
163344216A simple salting out procedure for extracting DNA from human nucleated cells.Nucleic Acids Res1988https://conductscience.org/library/papers/3344216PubMed
1728811688Genetic Variation in CD166 Gene and Its Association with Bladder Cancer Risk in North Indian Population.Indian J Clin Biochem2017https://conductscience.org/library/papers/28811688PubMed
1825108577Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer.Eur Urol2015https://conductscience.org/library/papers/25108577PubMed
1933538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
2018279810Activated leukocyte cell adhesion molecule: a new paradox in cancer.Transl Res2008https://conductscience.org/library/papers/18279810PubMed

See all 52 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
36795805CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses.Science2023https://conductscience.org/library/papers/36795805PubMed
35767366Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.Prostate2022https://conductscience.org/library/papers/35767366PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35767366

GET https://conductscience.org/api/papers/v1/35767366/references?page=2